Company: SXTPW
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001213900-25-008463
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 1.01
Chunk 2
---
 upon issuance, or
January 30, 2025, for twenty-four months from the date of issuance, or January 30, 2027.

The
Company received net proceeds of approximately $804,346.40 from the offering, after deducting estimated offering expenses paid by the
Company, including the Placement Agent fees. The Company intends to use the net proceeds from the offering for general
corporate purposes, including working capital.

The Engagement Agreement, as amended, form of Securities Purchase Agreement, form of Warrant, and form of Placement Agent Warrant are
filed as Exhibits 1.1, 1.2, 1.3, 10.1, 4.1 and 4.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
The above descriptions of the terms of the Securities Purchase Agreement and Warrant are qualified in their entirety by reference to such
exhibits.

Item
3.02. Unregistered Sales of Equity Securities.

The
disclosures set forth in Item 1.01 of this Current Report on Form 8-K (this “ Report”)
with respect to the Warrants, the Warrant Shares, the Placement Agent Warrants and the shares
of Common Stock issuable thereunder are hereby incorporated by reference into this Item 3.02.

Item 8.01.
Other Events.

On
January 29, 2025, the Company issued a press release announcing the pricing of the offering. A copy of the press release announcing this
matter is filed as Exhibit 99.1 to this Report and is incorporated by reference into this Item 8.01.

On
January 30, 2025, the Company issued a press release announcing the closing of the offering. A copy of the press release announcing this
matter is filed as Exhibit 99.2 to this Report and is incorporated by reference into this Item 8.01.

Item 9.01.
Exhibits.

  (d)      Exhibits  

  Exhibit      Description                                                            
      No.                                                                             
 ──────────────────────────────────────────────────────────────────────────────────────
      1.1      Engagement Agreement                                                   
      1.2      Amendment to Engagement Agreement                                      
      1.3      Extension to Engagement Agreement                                      
      4.1      Form                                                                   
      4.2      Form                                                                   
      5.1      Opinion                                                                
     10.1